Virax Biolabs Group Ltd (VRAX) Total liabilities 2021–2025
Virax Biolabs Group Ltd (VRAX) total liabilities at each fiscal year-end, per SEC filings.
$730,783FY2025 · since FY2021: $690,303 → $730,783
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $730,783 | +523.5% |
| FY2024 | $117,212 | -82.9% |
| FY2023 | $686,002 | -33.0% |
| FY2022 | $1.0M | +48.2% |
| FY2021 | $690,303 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Gross marginVRAX Operating incomeVRAX Operating marginVRAX Operating cash flowVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Shareholders’ equityVRAX overview →